Tech-enabled bio

Permeable peptide graphic
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
→
Opportunities and Challenges of Applying Generative AI to Designing New Drugs
→
Evan Feinberg, CEO of Genesis Therapeutics
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
→
Video: Early Cancer Detection With Delfi
→
Video: Reengineering Drug Discovery With Recursion
→